Chemical Management

Overview of Amazon Web Services

June 3, 2022

Overview of
Amazon Web Services offers a broad set of global cloud-based products including compute, storage, databases, analytics, networking, mobile, developer tools,

Spotlight

Achillion Pharmaceuticals, Inc.

Achillion Pharmaceuticals, Inc. is a science-driven, patient-focused company leveraging its strengths across the continuum from drug discovery to commercialization to provide better treatments for people with serious diseases. Achillion’s rational, iterative approach to discovery and development has created a powerful engine for advancing novel small-molecule drugs. Achillion pairs this rigorous science with insights about patients, caregivers, and the healthcare market to choose product candidates with disruptive potential – or the potential to change treatment paradigms. This has already enabled Achillion to generate three clinical-stage oral chronic hepatitis C (HCV) candidates and a proprietary library of over 1,300 potent and specific complement inhibitors. The company’s commitments to scientific excellence and market impact are reinforced by a culture that encourages cross-functional collaboration, organizational nimbleness and resilience, professional courage, and informed risk-

OTHER WHITEPAPERS
news image

CHARACTERIZING POSTCONSUMER RESIN WITHMATERIALS ANALYSIS

whitePaper | July 20, 2022

It’s impossible to think about plastics without picturing piles of soda bottles, filmy food wrappers, and other packaging floating in the ocean or washing up on the shore.

Read More
news image

Green Chemistry and Contract Synthesis – a Contradiction?

whitePaper | June 17, 2021

The topic of green chemistry is now also a challenge for contract synthesis suppliers. This is because more and more manufacturers of shampoos, detergents, paints, packaging and other consumer products are becoming increasingly concerned about the ecological footprint of their products. The trend is being fueled by consumers, who are increasingly prepared to spend more money on products that are better for the environment. But the political environment is also exerting major pressure on companies.

Read More
news image

Technology options for CO2- emission reduction of hydrogen feedstock in ammonia production

whitePaper | February 19, 2022

Ammonia is a focal point for the development of the hydrogen economy. As the main intermediate product used in fertilizer production, ammonia is also the main building block for mineral fertilizers.

Read More
news image

First Sustainable Circular Economy Token

whitePaper | March 12, 2022

According to the United Nations, we dump more than 2 billion tonnes of waste every year. Global waste could grow to 3.40 billion tonnes by 2050, more than double population growth over the same period.

Read More
news image

Chemical Manufacture PROTECTING CRITICAL PROCESS CONTROL NETWORKS

whitePaper | December 27, 2019

chemical company, serves customers globally in over 90 countries. With over $30 billion in revenue, they provide coatings, paper and plastics products for agriculture, nutrition, electronics and many other industries. They operate a sophisticated set of process control systems to manage the quality and safety of their chemical plant operations.

Read More
news image

WORLD SCALECRUDE TO OLEFINS

whitePaper | December 1, 2022

The Crude-to-Chemicals project is designed for world-scale petrochemicals production to deliver a flexible, bankable, and sustainable free-market investment. Through strong cooperation with the customer, Honeywell UOP has developed a configuration that enables 100% net olefins derived products.

Read More

Spotlight

Achillion Pharmaceuticals, Inc.

Achillion Pharmaceuticals, Inc. is a science-driven, patient-focused company leveraging its strengths across the continuum from drug discovery to commercialization to provide better treatments for people with serious diseases. Achillion’s rational, iterative approach to discovery and development has created a powerful engine for advancing novel small-molecule drugs. Achillion pairs this rigorous science with insights about patients, caregivers, and the healthcare market to choose product candidates with disruptive potential – or the potential to change treatment paradigms. This has already enabled Achillion to generate three clinical-stage oral chronic hepatitis C (HCV) candidates and a proprietary library of over 1,300 potent and specific complement inhibitors. The company’s commitments to scientific excellence and market impact are reinforced by a culture that encourages cross-functional collaboration, organizational nimbleness and resilience, professional courage, and informed risk-

Events